TB DRUG MONOGRAPHS
Baseline & Ongoing Monitoring Tests
We value your comments and feedback. Please email
The information we have provided here is not exhaustive and is aimed as a practical tool for aid in the management of patients with MDR-TB. A list of references is included in a separate document however the majority of these recommendations are based on expert consensus.
is welcomed. This is a drug monitoring guideline, for treatment guidance please refer to the WHO treatment guideline
and the BTS MDR-TB Clinical Advisory Service